Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion. They are infused when administered intravenously (IV), or injected when administered intramuscularly (IM), or subcutaneously into the human body. A large volume parenteral (LVP) is a unit dose container of greater than 100ml that is terminally sterilized by heat. Small volume parenteral (SVP) is a "catch-all" for all non-LVP parenterals products except biologicals.
This report contains market size and forecasts of Parenteral Drugs in global, including the following market information:
Global Parenteral Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Parenteral Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Parenteral Drugs companies in 2021 (%)
The global Parenteral Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
LVP Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Parenteral Drugs include Ostuka Pharmaceutical, Teva Pharmaceutical Industries, Kelun Pharma, Cook Pharmica, Patheon, BAG Healthcare, Beximco Pharma, Baxter Healthcare Corporation and B. Braun, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Parenteral Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parenteral Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Parenteral Drugs Market Segment Percentages, by Type, 2021 (%)
LVP Drug
SVP Drug
Global Parenteral Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Parenteral Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Medical Centers
Others
Global Parenteral Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Parenteral Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Parenteral Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Parenteral Drugs revenues share in global market, 2021 (%)
Key companies Parenteral Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Parenteral Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott